Parameters of iron deficiency in children with cyanotic congenital heart disease.
A group of 67 children with cyanotic congenital heart disease (CCHD) were studied, and 35 were given iron treatment according to a regimen that gives iron to patients with a hematocrit (Hct) below 60%. The patients were categorized as iron-deficient and iron-sufficient according to their transferrin saturation and ferritin values. The pretreatment hemoglobin (Hb) and Hct values of the groups were similar. The mean Hct was nearly three times as much as the mean Hb in the iron-sufficient group and more than three times as much as the Hb in the iron-deficient group. Excessive erythrocytosis in the iron-deficient group was impressive. Mean corpuscular volume (MCV) values were below 72.7 fl in all of the iron-deficient patients. After treatment the Hb, Hct, transferrin saturation, and ferritin increased significantly in both groups, with the increments greater in the iron-deficient group. Increments in the erythrocyte (RBC) count were significant in the iron-sufficient group but insignificant in the iron-deficient one. Increments of MCV in the iron-deficient group were significant but insignificant in the iron-sufficient group. Our study demonstrated that prediction of Hb, RBC count, and MCV, measurements of which are easy and inexpensive and require little blood, can suffice for the diagnosis of iron deficiency in patients with CCHD without altering systemic perfusion.
Olcay
L
L
Department of Pediatrics, Hacettepe University Faculty of Medicine, 06100 Ankara Turkey.
Ozer
S
S
Gürgey
A
A
Saraçlar
M
M
Ozme
S
S
Bilgiç
A
A
Ozkutlu
S
S
Celiker
A
A
D000747:Anemia, Hypochromic / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D004906:Erythrocyte Count; D004909:Erythrocyte Indices; D005260:Female; D005293:Ferritins / Q000097:blood; D006330:Heart Defects, Congenital / Q000097:blood / Q000150:complications*; D006400:Hematocrit; D006454:Hemoglobins; D006801:Humans; D015994:Incidence; D007223:Infant; D007501:Iron / Q000627:therapeutic use; D000090463:Iron Deficiencies; D008297:Male; D014168:Transferrin / Q000378:metabolism
D006454:Hemoglobins; D014168:Transferrin; D005293:Ferritins; D007501:Iron